Clinical Safety and Tolerability Study of gpASIT+TM and gpASIT+TM/Immunoregulating Adjuvant to Treat Seasonal Grass Pollen Rhinoconjunctivitis

Clinical trial NCT01111279 · COMPLETED

Trial details

NCT number: NCT01111279
Sponsor: BioTech Tools S.A.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Seasonal Allergic Rhinoconjunctivitis

Start date: 2010-03-01
Primary completion: 2010-09-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.